Skip to content

Comparison of the effects of local anesthetics on the severity of pain after cesarean section

Comparing the analgesic effect of bupivacaine, bupivacaine with adrenaline and bupivacaine with Epsom on the pain after cesarean section

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015090723926N1
Enrollment
160
Registered
2016-02-18
Start date
2015-07-29
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia and delivery. Complications of anaesthesia during labour and delivery

Interventions

Intervention 1: Intervention Group(1): 50 milliliter normal saline is injected intravenously during 15 minutes at the beginning of surgery .then 10 milliliter of 0.5%bupivacaine which is diluted with
Treatment - Drugs
Placebo
Intervention Group(1): 50 milliliter normal saline is injected intravenously during 15 minutes at the beginning of surgery .then 10 milliliter of 0.5%bupivacaine which is diluted with 10 milliliter o
Intervention group (2): At the beginning of surgery 50 milliliter normal saline intravenously injected. Then 0.1 milliliter of adrenaline 1:1000 + 10 milliliter of 0.5% bupivacaine is diluted with nor
Intervention group (3): 50 milligrams per kilogram of magnesium sulfate 50% by volume of 50 milliliter normal saline can be injected intravenously over 15 minutes And 10 milliliter 0.5% bupivacaine wi
Control group: 50 milliliter normal saline injected intravenously over 15 minutes, and 20 milliliter normal saline injected in subcutaneous fat after repairing fascia

Sponsors

Vice chancellor for research, Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Term Pregnancy; single pregnancy; ASA class I or II; Height 180 to 170 cm,; End pregnancy weight from 100 to 70 kg and undergoing elective cesarean section. Exclusion criteria: having hypersensitivity to amide local anesthetics (eg, bupivacaine and lidocaine), magnesium sulfate and epinephrine; history of opioid drugs; coagulopathy; seizure; cardiovascular disease; mental disorders; asthma and chronic obstructive pulmonary disease; high ICP; kidney disease; liver disease; atrioventricular block; history of calcium channel blockers; A tonic uterus after surgery or prolong surgical time more than 1.5 hours

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of pain. Timepoint: 2, 6, 12, 18 and 24 hours after after starting the intervention. Method of measurement: visual Analogous Scale of pain.

Secondary

MeasureTime frame
Blood pressure. Timepoint: 2, 6, 12, 18 and 24 hours after starting intervention. Method of measurement: Observation and record.;Heart rate. Timepoint: 2, 6, 12, 18 and 24 hours after starting intervention. Method of measurement: Observation and record.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRabeeh Rouhani

Babol university of medical science

R.Rouhani@mubabol.ac.ir+98 11 3223 8256

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026